Partnership will support efforts to sequence and analyze the spread and evolution of the SARS-CoV-2 virus and how it affects patients
Over the last weeks, the McGill Genome Centre has established a partnership with the COVID-19 Genomics UK (COG-UK) consortium to work together to share knowledge and protocols. The Centre is pleased to announce that the partnership has now been extended to the newly formed Canadian COVID Genomics Network (CanCOGeN) as it launches a national sequencing network to monitor the pandemic’s development.
By sharing knowledge, lessons learned and protocols, the initiatives will each support national efforts to coordinate the work of healthcare, public, private and academic organizations to sequence and analyze the spread and evolution of the SARS-CoV-2 virus and how it affects patients. The partnership will also allow both groups to share insights and discoveries to drive understanding of the pandemic as it changes over time.
Professor Mark Lathrop, a member of CanCOGeN and Scientific Director of the McGill Genome Centre said, “We are excited to be working with COG-UK and researchers elsewhere to share our discoveries and insights into the action, evolution and spread of the COVID-19 pandemic. Combining the skills, knowledge and insights of the international research community will enable us all to more rapidly understand, and formulate strategies to counter, this global health threat.”
Read the announcement of the partnership between CanCOGeN and COG-UK